查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945385

2026年全球胰島素輸注裝置市場報告

Insulin Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，胰島素輸注裝置市場成長顯著，預計將從2025年的190.7億美元成長到2026年的206.1億美元，複合年成長率為8.1%。過去幾年的成長可歸因於糖尿病盛行率的上升、糖尿病管理意識的提高、胰島素治療的普及、醫療保健服務的改善以及自行注射的增加。

預計未來幾年，胰島素輸注裝置市場將維持強勁成長，2030年市場規模將達到280.3億美元，複合年成長率（CAGR）為8.0%。預測期內的成長可歸因於以下因素：全球糖尿病盛行率不斷上升、對便捷胰島素給藥方式的需求日益成長、對長期糖尿病管理的日益重視、新興市場糖尿病護理服務覆蓋範圍的擴大以及居家醫療解決方案的普及。預測期內的主要趨勢包括：胰島素筆作為傳統注射器的替代品得到更廣泛的應用、對用於持續胰島素輸注的胰島素幫浦的需求不斷成長、對易於使用和攜帶式胰島素裝置的偏好日益增強、家庭糖尿病管理解決方案的擴展以及一次性及預填充胰島素輸注裝置的使用量增加。

預計未來幾年，糖尿病盛行率的不斷上升將推動胰島素輸注裝置市場的成長。糖尿病是一種慢性疾病，由於胰臟胰島素分泌不足或人體無法有效利用胰島素，導致血糖值升高。糖尿病患者人數的增加主要歸因於缺乏運動、飲食不健康以及全球肥胖率上升等因素。胰島素輸注裝置對於糖尿病管理至關重要，因為它們能夠以可控的方式輸注胰島素，有效控制血糖值，預防併發症並促進健康。例如，根據總部位於比利時的非政府組織國際糖尿病聯盟（IDF）統計，截至2024年，全球約有5.89億20至79歲的成年人患有糖尿病。預計到2050年，這數字將達到8.53億。糖尿病盛行率的不斷上升正在推動胰島素輸注裝置市場的擴張。

胰島素輸注設備市場的主要企業正致力於開發創新產品，例如能夠實現持續或個人化胰島素輸注的胰島素幫浦。胰島素幫浦是可程式設計醫療設備，可透過皮下植入的導管持續或按需輸注胰島素。例如，2023年5月，總部位於美國的醫療科技公司Beta Bionics的iLet ACE胰島素幫浦和iLet劑量決策軟體獲得了美國食品藥物管理局（FDA）的核准。 iLet仿生胰臟系統專為6歲及以上第1型糖尿病患者設計，整合了兩個設備以及一個相容的、已獲FDA批准的整合式連續血糖監測儀（iCGM）。本系統採用自適應閉合迴路演算法，作為自動胰島素輸注（AID）系統運行，設定時僅需使用者的體重，無需其他胰島素輸注參數。與傳統的胰島素幫浦治療不同，該系統無需手動調整設置，因此易於實施和管理。此外，iLet設備還具有餐前提醒功能，並透過將餐點分為小份、中份和大份，簡化了餐前胰島素的給藥。該演算法會隨著時間的推移學習並適應您個人的胰島素需求。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球胰島素輸注裝置市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
  • 主要趨勢
    • 與傳統注射器相比，胰島素筆的使用率正在不斷提高。
    • 對用於持續胰島素輸注的胰島素幫浦的需求不斷成長
    • 消費者越來越傾向選擇操作簡單、便攜的胰島素設備。
    • 拓展居家糖尿病管理解決方案
    • 一次性預填充胰島素輸注裝置的使用日益增多

第5章 終端用戶產業市場分析

  • 醫院
  • 糖尿病診所或中心
  • 居家醫療環境
  • 門診治療中心
  • 內分泌專科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球胰島素輸注裝置市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球胰島素輸注裝置市場規模、比較及成長率分析
  • 全球胰島素輸注裝置市場表現：規模與成長，2020-2025年
  • 全球胰島素輸注裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 胰島素注射器、胰島素噴射注射器、筆針、可重覆使用胰島素筆、拋棄式胰島素筆
  • 按疾病指徵
  • 類型 1，類型 2
  • 透過分銷管道
  • 醫院藥局、零售藥局、線上零售商、糖尿病診所或中心
  • 依類型細分：胰島素注射器
  • 標準胰島素注射器，包括固定針長或可調節針長的胰島素注射器
  • 依類型細分：胰島素噴射注射器
  • 無針胰島素噴射注射器，高壓胰島素噴射注射器
  • 按類型細分：注射筆針
  • 短筆針，長筆針
  • 依類型細分：可重複使用胰島素筆
  • 可重複使用的筆，附有可更換筆芯，可填充胰島素筆
  • 按類型細分：拋棄式胰島素筆
  • 拋棄式胰島素筆，預填充式拋棄式胰島素筆

第10章 區域與國家分析

  • 全球胰島素輸注裝置市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球胰島素輸注裝置市場：國家、實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 胰島素輸注裝置市場：競爭格局及市佔率（2024年）
  • 胰島素輸注裝置市場：公司估值矩陣
  • 胰島素輸注裝置市場：公司概況
    • Novo Nordisk A/S
    • Medtronic Plc
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • Ypsomed Holding AG

第37章：其他領先和創新企業

  • Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年胰島素輸注裝置市場：提供新機會的國家
  • 2030年胰島素輸注裝置市場：充滿新機會的細分市場
  • 2030年胰島素輸注裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MIDDE01_G26Q1

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

Tariffs have introduced cost pressures in the insulin delivery devices market by increasing duties on imported medical-grade plastics, electronic components, and precision manufacturing equipment. These impacts have raised production and distribution costs, particularly affecting insulin pumps, smart devices, and pen-based delivery systems, with north america and asia-pacific regions experiencing higher exposure due to globalized supply chains. Healthcare providers and pharmacies have faced pricing pressures that influence device affordability and adoption. On the positive side, tariffs have encouraged local manufacturing, regional sourcing of components, and supply chain diversification, supporting long-term production resilience.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $19.07 billion in 2025 to $20.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of diabetes, growing awareness of diabetes management, increased availability of insulin therapies, expansion of healthcare access, rising adoption of self-injection practices.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $28.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing global diabetic population, rising demand for convenient insulin delivery methods, growing focus on long-term diabetes management, expanding access to diabetes care in emerging markets, increasing adoption of home healthcare solutions. Major trends in the forecast period include rising adoption of insulin pens over traditional syringes, growing demand for insulin pumps for continuous insulin delivery, increasing preference for user-friendly and portable insulin devices, expansion of home-based diabetes management solutions, growing use of disposable and pre-filled insulin delivery devices.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the International Diabetes Federation, a Belgium-based non-governmental organization, in 2024, approximately 589 million adults aged 20-79 were living with diabetes worldwide. This figure is projected to rise to 853 million by 2050. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens
  • 2) By Disease Indication: Type 1; Type 2
  • 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
  • Subsegments:
  • 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
  • 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
  • 3) By Pen Needles: Short Pen Needles; Long Pen Needles
  • 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
  • 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
  • Companies Mentioned: Novo Nordisk A/S; Medtronic Plc; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Becton Dickinson and Company; Sanofi SA; Eli Lilly and Company; Abbott Laboratories; EOFlow Co. Ltd.; Beta Bionics Inc.; Bigfoot Biomedical Inc.; CeQur Corporation; Emperra GmbH; Debiotech SA; AMF Medical SA; Aerami Therapeutics Inc.; Andain Inc.; Apex Medical Devices; Animas Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Insulin Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Insulin Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Insulin Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Insulin Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Insulin Pens Over Traditional Syringes
    • 4.2.2 Growing Demand For Insulin Pumps For Continuous Insulin Delivery
    • 4.2.3 Increasing Preference For User-Friendly And Portable Insulin Devices
    • 4.2.4 Expansion Of Home-Based Diabetes Management Solutions
    • 4.2.5 Growing Use Of Disposable And Pre-Filled Insulin Delivery Devices

5. Insulin Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diabetes Clinics Or Centers
  • 5.3 Home Care Settings
  • 5.4 Ambulatory Care Centers
  • 5.5 Specialty Endocrinology Clinics

6. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Insulin Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Insulin Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Insulin Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Insulin Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Insulin Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Insulin Delivery Devices Market Segmentation

  • 9.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens
  • 9.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Type 1, Type 2
  • 9.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
  • 9.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
  • 9.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
  • 9.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Short Pen Needles, Long Pen Needles
  • 9.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
  • 9.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

10. Insulin Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Insulin Delivery Devices Market

  • 11.1. Asia-Pacific Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Insulin Delivery Devices Market

  • 12.1. China Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Insulin Delivery Devices Market

  • 13.1. India Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Insulin Delivery Devices Market

  • 14.1. Japan Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Insulin Delivery Devices Market

  • 15.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Insulin Delivery Devices Market

  • 16.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Insulin Delivery Devices Market

  • 17.1. South Korea Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Insulin Delivery Devices Market

  • 18.1. Taiwan Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Insulin Delivery Devices Market

  • 19.1. South East Asia Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Insulin Delivery Devices Market

  • 20.1. Western Europe Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Insulin Delivery Devices Market

  • 21.1. UK Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Insulin Delivery Devices Market

  • 22.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Insulin Delivery Devices Market

  • 23.1. France Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Insulin Delivery Devices Market

  • 24.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Insulin Delivery Devices Market

  • 25.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Insulin Delivery Devices Market

  • 26.1. Eastern Europe Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Insulin Delivery Devices Market

  • 27.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Insulin Delivery Devices Market

  • 28.1. North America Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Insulin Delivery Devices Market

  • 29.1. USA Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Insulin Delivery Devices Market

  • 30.1. Canada Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Insulin Delivery Devices Market

  • 31.1. South America Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Insulin Delivery Devices Market

  • 32.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Insulin Delivery Devices Market

  • 33.1. Middle East Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Insulin Delivery Devices Market

  • 34.1. Africa Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Insulin Delivery Devices Market Regulatory and Investment Landscape

36. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Insulin Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Insulin Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Insulin Delivery Devices Market Company Profiles
    • 36.3.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tandem Diabetes Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

37. Insulin Delivery Devices Market Other Major And Innovative Companies

  • Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

38. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

40. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Insulin Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Insulin Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Insulin Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer